Stay updated on Faricimab in Diabetic Macular Edema Clinical Trial
Sign up to get notified when there's something new on the Faricimab in Diabetic Macular Edema Clinical Trial page.

Latest updates to the Faricimab in Diabetic Macular Edema Clinical Trial page
- Check2 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for the completed Phase 3 RHINE study of faricimab for diabetic macular edema, including study details, results, documents, and publications.SummaryDifference100%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0; the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA banner was added announcing changes to NIH website terminology and linking to transition updates and FAQs.SummaryDifference1%

- Check30 days agoChange DetectedThe footer revision changes from v3.7.1 to v3.7.2 while the page remains a 403 Forbidden error page.SummaryDifference0.2%

- Check37 days agoChange DetectedThe ClinicalTrials.gov 403 error page displays an updated site revision number, from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check44 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the usual content and indicating restricted access to the study record. This reflects an access issue that prevents viewing the trial details.SummaryDifference19%

Stay in the know with updates to Faricimab in Diabetic Macular Edema Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Faricimab in Diabetic Macular Edema Clinical Trial page.